Business

medmix' Shareholders Approve All Proposals at Annual General Meeting 2026

medmix AG Neuhofstrasse 20 CH-6430 Baar [email protected] www.medmix.swiss DOWNLOAD MEDIA RELEASE MEDIA RELEASE April 16, 2026 medmix’ Shareholders Approve All Proposals at Annual General Meeting 2026 At today’s annual general meeting (AGM) of medmix Ltd., shareholders approved all proposals of the Board of Directors. medmix will pay an ordinary dividend of CHF 0.10 per share. Baar, Switzerland--(Newsfile Corp. - April 16, 2026) -...

articleMedmix AgApril 16, 20262/company/medmix-ag/news/medmix-shareholders-approve-all-proposals-at-annual-general-meeting-2026
medmix' Shareholders Approve All Proposals at Annual General Meeting 2026

About this update from Medmix Ag

[{"type":"text","content":"medmix AG Neuhofstrasse 20 CH-6430 Baar [email protected] www.medmix.swiss","length":87,"tagName":"p"},{"type":"text","content":"DOWNLOAD MEDIA RELEASE","length":22,"tagName":"p"},{"type":"text","content":"MEDIA RELEASE","length":13,"tagName":"p"},{"type":"text","content":"April 16, 2026","length":14,"tagName":"p"},{"type":"text","content":"medmix’ Shareholders Approve All Proposals at Annual General Meeting 2026","length":73,"tagName":"p"},{"type":"text","content":"At today’s annual general meeting (AGM) of medmix Ltd., shareholders approved all proposals of the Board of Directors. medmix will pay an ordinary dividend of CHF 0.10 per share.","length":178,"tagName":"p"},{"type":"text","content":"Baar, Switzerland--(Newsfile Corp. - April 16, 2026) - medmix' shareholders approved all proposals of the company’s Board of Directors at its AGM 2026. The shareholders approved the Annual Report 2025, including the business review, the financial statements of medmix Ltd, the consolidated financial statements 2025 as well as the appropriation of the annual result and the Sustainability Report.","length":400,"tagName":"p"},{"type":"text","content":"An ordinary dividend of CHF 0.10 per share will be paid out on April 22, 2026. In a consultative vote, the shareholders approved the compensation report of medmix. Discharge was granted to all members of the Board of Directors and of the Executive Committee. The remuneration limits for the Board of Directors for the period from AGM 2026 to AGM 2027, and for the Executive Committee for the financial year 2027, were approved as well.","length":435,"tagName":"p"},{"type":"text","content":"Rob ten Hoedt was re-elected as Chairman of the Board of Directors, and the shareholders confirmed all members of the Board and of the Nomination & Remuneration Committee. KPMG was confirmed as auditor and Proxy Voting Services GmbH was re-elected as the independent proxy.","length":277,"tagName":"p"},{"type":"text","content":"The minutes of the AGM 2026 will be published within the statutory period on www.medmix.swiss.","length":94,"tagName":"p"},{"type":"text","content":"Inquiries","length":9,"tagName":"p"},{"type":"text","content":"Investor Relations: [email protected]","length":48,"tagName":"p"},{"type":"text","content":"Media Relations: [email protected]","length":42,"tagNa...

More updates from Medmix Ag

Board of DirectorsAnnual General Meetingconsolidated financial statementsmedmix AGShareholders